novo nordisk tirzepatide Pharmaceutical companies and Eli Lilly are facing off in court over ads for their competing weight loss and diabetes drugs, with Novo claiming Lilly's campaigns give consumers a misleading picture Novo Nordisk A/S is suing

Steer clear of that road

Skin soothing essence that can be used for whitening with moisture care

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

How Your Genetics Relate to GLP-1 Pathways Your genes influence how your digestive system responds to GLP-1 medications

Our creatine supplement guide is a better first stop for most lifters chasing measurable gym performance